Skip to main content
Premium Trial:

Request an Annual Quote

Institute Launches to Match Patients With Most Appropriate Drugs

NEW YORK (GenomeWeb) – The non-profit Transforming Medicine: The Elizabeth Kauffman Institute (TMed), which seeks to match patients with life-threatening diseases with the most appropriate treatments, officially launched today. 

Founded by Institute for Systems Biology President Lee Hood and others, Cambridge, Massachusetts-based TMed plans to develop a knowledgebase for evaluating patient information, including genetic and molecular data, to determine the best marketed and research-stage treatment for each individual. 

Researchers at the institute will develop unique algorithms that can predict the most effective therapies for difficult-to-treat ailments including pancreatic cancer, brain cancer, and sickle cell anemia, TMed said. 

The other founders of the institute include Colin Hill, CEO of GNS Healthcare; Robert Goldberg, vice president and co-founder of the Center for Medicine in the Public Interest; Kathleen O'Connell, a patient advocate; and Stuart Kauffman, a systems biology expert at the University of Vermont. 

The institute is named for Kauffman's wife Elizabeth who died in 2013 from pancreatic cancer. 

"We formed this institute because over half the medicines used today do not work for half the patients," Hood said in a statement. "This is particularly true for people fighting the most complex and fatal diseases. Our aim is to change the practice of medicine in a fundamental way."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.